Nexalis Therapeutics 

Lifespot Health Ltd. (LSH.AX), based in Melbourne, Victoria, is dedicated to the creation and commercialization of sophisticated medical diagnostic and monitoring technologies, as well as digital platforms for drug delivery. The company's primary focus revolves around two key products: the BodyTel System and the Lifespot Skin System. The BodyTel System is engineered to facilitate the comprehensive management of chronic illnesses. It precisely tracks crucial physiological indicators, including blood glucose, blood pressure, and body weight. Additionally, it supports the oversight of prescribed therapeutic plans, covering aspects like medication intake, dietary adherence, and physical activity levels. This integrated system comprises a BodyTel Sensor, a dedicated BodyTel App, a robust BodyTel backend system, and an accessible BodyTel Webportal. Currently in its development phase, the Lifespot Skin System is designed to function through a specialized mobile application. This emerging digital health solution aims to equip both medical professionals and patients with advanced tools for the diagnosis and ongoing care of dermatological conditions. Ultimately, Lifespot Health is committed to delivering innovative digital healthcare solutions that aid clinicians and enhance patient involvement in their own health management.